- Home
- SRPT vs WLYB Comparison
SRPT vs WLYB Comparison
Compare SRPT & WLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- WLYB
- Stock Information
- Founded
- SRPT 1980
- WLYB 1807
- Country
- SRPT United States
- WLYB United States
- Employees
- SRPT N/A
- WLYB N/A
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- WLYB Books
- Sector
- SRPT Health Care
- WLYB Consumer Discretionary
- Exchange
- SRPT Nasdaq
- WLYB Nasdaq
- Market Cap
- SRPT 2.0B
- WLYB 2.1B
- IPO Year
- SRPT 1997
- WLYB N/A
- Fundamental
- Price
- SRPT $18.46
- WLYB $39.85
- Analyst Decision
- SRPT Hold
- WLYB
- Analyst Count
- SRPT 30
- WLYB 0
- Target Price
- SRPT $44.37
- WLYB N/A
- AVG Volume (30 Days)
- SRPT 9.6M
- WLYB 177.0
- Earning Date
- SRPT 08-06-2025
- WLYB 09-04-2025
- Dividend Yield
- SRPT N/A
- WLYB 3.61%
- EPS Growth
- SRPT N/A
- WLYB N/A
- EPS
- SRPT N/A
- WLYB 1.53
- Revenue
- SRPT $2,481,531,000.00
- WLYB $1,677,609,000.00
- Revenue This Year
- SRPT $9.41
- WLYB $1.45
- Revenue Next Year
- SRPT N/A
- WLYB $2.70
- P/E Ratio
- SRPT N/A
- WLYB $25.16
- Revenue Growth
- SRPT 64.89
- WLYB N/A
- 52 Week Low
- SRPT $10.42
- WLYB $36.70
- 52 Week High
- SRPT $138.81
- WLYB $52.90
- Technical
- Relative Strength Index (RSI)
- SRPT 48.03
- WLYB 39.68
- Support Level
- SRPT $17.95
- WLYB $39.63
- Resistance Level
- SRPT $19.61
- WLYB $42.70
- Average True Range (ATR)
- SRPT 1.20
- WLYB 0.02
- MACD
- SRPT -0.06
- WLYB 0.09
- Stochastic Oscillator
- SRPT 19.69
- WLYB 70.97
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About WLYB John Wiley & Sons Inc.
John Wiley & Sons Inc is one of the world's greatest publishers and a trusted leader in research and learning. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.